The owner of Phoenix Life Sciences, a CBD company based in Denver, was arrested on charges of securities fraud. One report indicates that 32 charges of securities fraud were brought against Tindall, and that the company also alleges that he was involved in the unregistered sale.
Tindall has also been sued by investors in 2013. The investors alleged that he siphoned off investment funds for personal use. Although the federal court ruled against Tindall, the decision was ultimately reversed based on a technicality. Investors later refiled the suit, and prevailed, reports Westword.